Showing results (181-190 of 259) with videos related to
Sort By:
Pageof 26
Medical Sciences (Basel, Switzerland)|November 24, 2025
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic ImagingGraziella Marino, Maria Valeria De Bonis, Marisabel Mecca, et al.Breast (Edinburgh, Scotland)|March 7, 2013
Gene expression profiling in breast cancer: a clinical perspectiveGrazia Arpino, Daniele Generali, Anna Sapino, et al.Antibiotics (Basel, Switzerland)|October 25, 2024
Beneficial Effects Induced by a Proprietary Blend of a New Bromelain-Based Polyenzymatic Complex Plus N-Acetylcysteine in Urinary Tract Infections: Results from In Vitro and Ex Vivo StudiesLucia Recinella, Morena Pinti, Maria Loreta Libero, et al.Scientific Reports|July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.Breast Cancer Research and Treatment|August 10, 2020
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Navid Sobhani, Anna Ianza, et al.Oncotarget|June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancerKatharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.Frontiers in Oncology|February 6, 2023
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicineElisa De Paolis, Ida Paris, Bruno Tilocca, et al.Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.Pageof 26